MUFG Securities Americas’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.13M Buy
171,660
+14,334
+9% +$375K 0.21% 82
2026
Q1
$4.42M Buy
157,326
+4,152
+3% +$111K 0.28% 63
2025
Q4
$3.81M Sell
153,174
-144
-0.1% -$3.63K 0.24% 80
2025
Q3
$3.91M Buy
153,318
+27,314
+22% +$674K 0.25% 76
2025
Q2
$3.05M Buy
126,004
+25,689
+26% +$599K 0.26% 73
2025
Q1
$2.54M Buy
100,315
+16,661
+20% +$436K 0.3% 66
2024
Q4
$2.22M Buy
+83,654
New +$2.27M 0.28% 66

Other funds holding PFE

MUFG Securities Americas's PFE Position: Q2 2026 in Review

MUFG Securities Americas increased its Pfizer (PFE) stake by 9.1% in Q2 2026, buying an estimated $375K and bringing the position to 171,660 shares worth $4.13M. The position accounts for 0.21% of the portfolio, ranked #82.

MUFG Securities Americas first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.42M in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MUFG Securities Americas held 171,660 shares of Pfizer worth $4.13M as of Q2 2026.
  • MUFG Securities Americas bought 14,334 Pfizer shares in Q2 2026, an estimated $375K.
  • Pfizer made up 0.21% of MUFG Securities Americas's portfolio in Q2 2026, its #82 holding.
  • MUFG Securities Americas first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • MUFG Securities Americas's Pfizer position peaked at $4.42M in Q1 2026.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.